funding-eu EU Horizon Europe HORIZON-MISS-2027-02 HORIZON-MISS-2027-02-CANCER-01 Anticancer therapy Cancer and its biological basis Epigenetics and gene regulation

Leveraging functional genomics to reveal novel targets for cancer treatment

EU — Italia · scadenza 21/09/2027

Leveraging functional genomics to reveal novel targets for cancer treatment

Scadenza: 21/09/2027

Fonte: eu_funding_tenders

Tipo: EU

Pagina ufficiale: Apri la scheda sulla fonte ufficiale

Scheda (fonte ufficiale)

Topic metadata

EU Programme: Horizon Europe (ID 43108390)
Call identifier: HORIZON-MISS-2027-02
Call name: Supporting the implementation of the Cancer Mission
Type: Topic
Opening date: 10/02/2027
Next deadline: 21/09/2027
Keywords: HORIZON-MISS-2027-02-CANCER-01, HORIZON-MISS-2027-02, Anticancer therapy, Cancer and its biological basis, Epigenetics and gene regulation, Genomics, comparative genomics, functional genomics

Topic description

Expected Outcome:

Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:

Researchers and health professionals gain a deeper understanding of the functional effects of tumour heterogeneity during cancer initiation and progression, supporting the identification of more precise and novel therapeutic targets.
Researchers, health professionals and innovators benefit from improved knowledge

Iscriviti o accedi per leggere e ricevere aggiornamenti sui finanziamenti.

Iscriviti ora